Inactive Instrument

Response Biomedical Corp Share Price

Equities

Duration

Period

Style

Response Biomedical Corp. : Completes Going-Private Transaction	29/11/16	MW
Response Biomedical : Announces Third Quarter Results	14/11/16	PU
Response Biomedical Corp. : Announces Third Quarter 2016 Financial Results and Update on Going-Private Transaction	10/11/16	MW
Response Biomedical Corp. : Receives Court Approval of Going-Private Transaction	19/09/16	MW
Response Biomedical Corp. : Receives Shareholder Approval of Going-Private Transaction	16/09/16	MW

Managers	Title	Age	Since
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-
Anastasios Tsonis DFI	Director of Finance/CFO	44	31/12/10
Eric Whitters COO	Chief Operating Officer	-	-

Members of the board	Title	Age	Since
Barbara Kinnaird-Steen CEO	Chief Executive Officer	56	-

Sector

	1st Jan change	Capi.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-1.52%	8.37B
DIASORIN S.P.A.	+10.68%	5.84B
LANTHEUS HOLDINGS, INC.	+26.94%	5.4B
AUTOBIO DIAGNOSTICS CO., LTD.	-5.09%	4.37B
10X GENOMICS, INC.	-52.54%	3.23B
ANDON HEALTH CO., LTD.	+14.18%	2.8B
MYRIAD GENETICS, INC.	+32.50%	2.26B
VITROLIFE AB	-6.47%	2.22B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-1.69%	1.87B